See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $3.6B | 8.0x | 20.8x | |
| $3.2B | 18.0x | 57.4x | |
| $2.4B | 3.1x | 17.7x | |
| $2.3B | 20.9x | -31.1x | |
| $2.2B | 88.0x | -64.4x | |
| $1.8B | 0.7x | 5.7x | |
| $1.8B | 11.8x | -6.1x | |
| $1.6B | 6.3x | 15.7x | |
| $1.2B | 5.3x | 15.6x | |
| $1.2B | 5.4x | 26.3x | |
| $929M | n/a | n/a | |
| $867M | n/a | n/a | |
| $841M | 4.2x | 17.8x | |
| $778M | 3.6x | 87.0x | |
| $673M | 7.9x | 22.3x | |
| $375M | 5.0x | n/a | |
| $339M | 133.7x | -1.9x | |
| $327M | 1.7x | 8.7x | |
| $240M | n/a | n/a | |
| $167M | n/a | -7.7x | |
| $158M | 6.0x | -6.6x | |
| $153M | 3.3x | n/a | |
| $131M | 2975.2x | -30.0x | |
| $122M | 1.3x | -12.4x | |
| $101M | 1.8x | -1.4x | |
| $26.2M | n/a | -0.2x | |
| -$5.7M | -0.2x | n/a | |
| -$25.9M | -0.3x | 0.3x | |
| -$30.9M | -7.5x | n/a | |
| -$39.5M | n/a | n/a | |
| -$62.0M | -2.0x | 0.6x | |
| -$96.9M | n/a | 0.8x | |
| -$206M | -5.2x | 1.1x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules